PUNE: Two patients from Pune district — a 57-year-old man and a 36-year-old woman — have undergone a radical cell therapy to treat the hip's AVN (Avascular Necrosis), also known as 'bone death syndrome' in the past 12 months.
Dr Ashish Arbat, senior joint replacement surgeon at Jehangir hospital said, "The AVN disease had restricted both patients' day-to-day activities. They were operated with bone-cell therapy using the country's first and only DCGI-approved Ossgrow, a targeted and personalised cell therapy-based solution to reverse the effects of AVN."
